Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-06-07

FDA Approved: LORAZEPAM — Supplemental Application (International Medication Systems, Limited)

View source ↗

Summary

FDA approved a supplemental application for lorazepam from International Medication Systems, Limited (ANDA 076150).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lorazepam (Lorazepam)

Snippet

SUPPL AP for LORAZEPAM (LORAZEPAM)